COVID-19 and Biomarkers: The Contribution of the Journal
Three years after coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization (WHO), several features of the pathogenesis and innate immune response to SARS-CoV-2 (severe acute respiratory syndrome coronavirus disease 2) have now been clarified [...]
Main Author: | Mario Plebani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/5/1853 |
Similar Items
-
Biomarkers of Hypercoagulability in COVID-19
by: Hideo Wada
Published: (2023-05-01) -
Current Issues, Challenges, and Future Perspectives in Clinical Laboratory Medicine
by: Ferdinando Mannello, et al.
Published: (2022-01-01) -
The Time Has Come to Understand the Mechanisms by Which Comorbidities Contribute to COVID-19 Severity
by: Bruno Mégarbane
Published: (2022-01-01) -
Distinguished Contributions in the Fields of Biomedical and Environmental Applications Incorporating Nanostructured Materials and Composites in Journal <i>Molecules</i>
by: Minas M. Stylianakis
Published: (2021-04-01) -
Coronavirus Disease Pathophysiology: Biomarkers, Potential New Remedies, Comorbidities, Long COVID-19, Post Pandemic Epidemiological Surveillance
by: Jacek Z. Kubiak, et al.
Published: (2023-07-01)